(-)-bornyl-caffeate decreases expression EXP 6480464 bornyl caffeate results in decreased expression of BCL2L2 CTD PMID:24907532 (1->4)-beta-D-glucan multiple interactions ISO Bcl2l2 (Mus musculus) 6480464 [perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of BCL2L2 mRNA CTD PMID:36331819 1,1,1-Trichloro-2-(o-chlorophenyl)-2-(p-chlorophenyl)ethane increases expression EXP 6480464 o and p'-DDT results in increased expression of BCL2L2 mRNA CTD PMID:22937105 1,1,1-Trichloro-2-(o-chlorophenyl)-2-(p-chlorophenyl)ethane decreases expression EXP 6480464 o and p'-DDT analog results in decreased expression of BCL2L2 mRNA CTD PMID:22937105 1,2-dimethylhydrazine decreases expression ISO Bcl2l2 (Mus musculus) 6480464 1 and 2-Dimethylhydrazine results in decreased expression of BCL2L2 mRNA CTD PMID:22206623 17beta-estradiol increases expression ISO BCL2L2 (Homo sapiens) 6480464 Estradiol results in increased expression of BCL2L2 mRNA CTD PMID:24481588 and PMID:31646340 17beta-estradiol affects expression EXP 6480464 Estradiol affects the expression of BCL2L2 mRNA CTD PMID:32145629 17beta-estradiol multiple interactions ISO BCL2L2 (Homo sapiens) 6480464 Estradiol inhibits the reaction [Fulvestrant results in increased expression of BCL2L2 mRNA] and Fulvestrant inhibits the reaction [Estradiol results in increased expression of BCL2L2 mRNA] CTD PMID:31646340 2,2',4,4'-Tetrabromodiphenyl ether decreases expression EXP 6480464 2 more ... CTD PMID:27291303 2,2',4,4'-Tetrabromodiphenyl ether increases expression ISO BCL2L2 (Homo sapiens) 6480464 2 more ... CTD PMID:27589474 2,3,7,8-tetrachlorodibenzodioxine decreases expression ISO BCL2L2 (Homo sapiens) 6480464 Tetrachlorodibenzodioxin results in decreased expression of BCL2L2 mRNA CTD PMID:16039398 2,3,7,8-tetrachlorodibenzodioxine decreases expression EXP 6480464 Tetrachlorodibenzodioxin results in decreased expression of BCL2L2 mRNA CTD PMID:33387578 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO Bcl2l2 (Mus musculus) 6480464 Tetrachlorodibenzodioxin affects the expression of BCL2L2 mRNA CTD PMID:21570461 2,3,7,8-tetrachlorodibenzodioxine increases expression ISO Bcl2l2 (Mus musculus) 6480464 Tetrachlorodibenzodioxin results in increased expression of BCL2L2 mRNA CTD PMID:14718646 and PMID:15972635 2,6-dinitrotoluene affects expression EXP 6480464 2 and 6-dinitrotoluene affects the expression of BCL2L2 mRNA CTD PMID:21346803 3-isobutyl-1-methyl-7H-xanthine multiple interactions ISO BCL2L2 (Homo sapiens) 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of BCL2L2 mRNA CTD PMID:28628672 4,4'-diaminodiphenylmethane increases expression ISO Bcl2l2 (Mus musculus) 6480464 4 and 4'-diaminodiphenylmethane results in increased expression of BCL2L2 mRNA CTD PMID:18648102 acrylamide decreases expression ISO BCL2L2 (Homo sapiens) 6480464 Acrylamide results in decreased expression of BCL2L2 mRNA CTD PMID:32763439 ammonium chloride affects expression EXP 6480464 Ammonium Chloride affects the expression of BCL2L2 mRNA CTD PMID:16483693 arsenite(3-) decreases expression ISO BCL2L2 (Homo sapiens) 6480464 arsenite results in decreased expression of BCL2L2 mRNA CTD PMID:31646340 arsenite(3-) multiple interactions ISO BCL2L2 (Homo sapiens) 6480464 arsenite inhibits the reaction [Fulvestrant results in increased expression of BCL2L2 mRNA] CTD PMID:31646340 arsenous acid decreases expression EXP 6480464 Arsenic Trioxide results in decreased expression of BCL2L2 mRNA CTD PMID:19730151 arsenous acid multiple interactions ISO BCL2L2 (Homo sapiens) 6480464 [Arsenic Trioxide co-treated with Curcumin] affects the expression of BCL2L2 protein CTD PMID:27430728 arsenous acid increases expression ISO BCL2L2 (Homo sapiens) 6480464 Arsenic Trioxide results in increased expression of BCL2L2 protein CTD PMID:27430728 atrazine multiple interactions ISO BCL2L2 (Homo sapiens) 6480464 [Atrazine co-treated with Arsenates] results in increased expression of BCL2L2 mRNA CTD PMID:18585445 atrazine decreases expression ISO BCL2L2 (Homo sapiens) 6480464 Atrazine results in decreased expression of BCL2L2 mRNA CTD PMID:22378314 benzo[a]pyrene affects expression ISO Bcl2l2 (Mus musculus) 6480464 Benzo(a)pyrene affects the expression of BCL2L2 mRNA CTD PMID:22641617 bisphenol A decreases expression ISO BCL2L2 (Homo sapiens) 6480464 bisphenol A results in decreased expression of BCL2L2 mRNA and bisphenol A results in decreased expression of BCL2L2 protein CTD PMID:21277958 and PMID:29275510 bisphenol A increases expression ISO BCL2L2 (Homo sapiens) 6480464 bisphenol A analog results in increased expression of BCL2L2 mRNA CTD PMID:32387340 bisphenol A decreases expression EXP 6480464 bisphenol A results in decreased expression of BCL2L2 mRNA CTD PMID:30816183 more ... bisphenol A affects expression ISO BCL2L2 (Homo sapiens) 6480464 bisphenol A affects the expression of BCL2L2 mRNA CTD PMID:30903817 bisphenol A multiple interactions ISO BCL2L2 (Homo sapiens) 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of BCL2L2 mRNA CTD PMID:28628672 bisphenol A increases expression EXP 6480464 bisphenol A results in increased expression of BCL2L2 mRNA CTD PMID:25181051 bortezomib increases expression ISO BCL2L2 (Homo sapiens) 6480464 Bortezomib results in increased expression of BCL2L2 mRNA CTD PMID:18928586 cadmium atom decreases expression EXP 6480464 Cadmium results in decreased expression of BCL2L2 protein CTD PMID:25388156 cadmium atom increases expression ISO BCL2L2 (Homo sapiens) 6480464 Cadmium results in increased expression of BCL2L2 mRNA CTD PMID:31646340 cadmium dichloride increases expression ISO Bcl2l2 (Mus musculus) 6480464 Cadmium Chloride results in increased expression of BCL2L2 mRNA CTD PMID:15501611 cadmium dichloride decreases expression ISO BCL2L2 (Homo sapiens) 6480464 Cadmium Chloride results in decreased expression of BCL2L2 mRNA and Cadmium Chloride results in decreased expression of BCL2L2 protein CTD PMID:12160620 carbon nanotube increases expression ISO BCL2L2 (Homo sapiens) 6480464 Nanotubes and Carbon results in increased expression of BCL2L2 mRNA CTD PMID:23634900 carnosic acid multiple interactions ISO BCL2L2 (Homo sapiens) 6480464 salvin inhibits the reaction [[Oxygen deficiency co-treated with Oxygen] results in decreased expression of BCL2L2 protein] CTD PMID:24557422 choline multiple interactions ISO Bcl2l2 (Mus musculus) 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of BCL2L2 mRNA CTD PMID:20938992 cisplatin multiple interactions ISO BCL2L2 (Homo sapiens) 6480464 [Cisplatin results in increased expression of MIR630] which results in decreased expression of BCL2L2 mRNA CTD PMID:21274007 cisplatin increases expression ISO Bcl2l2 (Mus musculus) 6480464 Cisplatin results in increased expression of BCL2L2 mRNA CTD PMID:23384965 clofibrate decreases expression ISO Bcl2l2 (Mus musculus) 6480464 Clofibrate results in decreased expression of BCL2L2 mRNA CTD PMID:23811191 cobalt dichloride decreases expression ISO BCL2L2 (Homo sapiens) 6480464 cobaltous chloride results in decreased expression of BCL2L2 mRNA CTD PMID:19376846 crocidolite asbestos increases expression ISO BCL2L2 (Homo sapiens) 6480464 Asbestos and Crocidolite results in increased expression of BCL2L2 mRNA CTD PMID:23634900 curcumin increases expression ISO BCL2L2 (Homo sapiens) 6480464 Curcumin results in increased expression of BCL2L2 mRNA CTD PMID:16101141 curcumin multiple interactions ISO BCL2L2 (Homo sapiens) 6480464 [arsenic trioxide co-treated with Curcumin] affects the expression of BCL2L2 protein CTD PMID:27430728 cyclophosphamide increases expression ISO Bcl2l2 (Mus musculus) 6480464 Cyclophosphamide results in increased expression of BCL2L2 mRNA CTD PMID:21041162 cyclosporin A increases expression ISO BCL2L2 (Homo sapiens) 6480464 Cyclosporine results in increased expression of BCL2L2 mRNA CTD PMID:20106945 DDE decreases expression EXP 6480464 Dichlorodiphenyl Dichloroethylene results in decreased expression of BCL2L2 mRNA CTD PMID:21384494 decabromodiphenyl ether decreases expression EXP 6480464 decabromobiphenyl ether results in decreased expression of BCL2L2 mRNA CTD PMID:23640034 deguelin decreases expression ISO BCL2L2 (Homo sapiens) 6480464 deguelin results in decreased expression of BCL2L2 mRNA CTD PMID:33512557 dexamethasone increases expression ISO Bcl2l2 (Mus musculus) 6480464 Dexamethasone results in increased expression of BCL2L2 mRNA CTD PMID:21041162 dexamethasone multiple interactions ISO BCL2L2 (Homo sapiens) 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of BCL2L2 mRNA CTD PMID:28628672 diarsenic trioxide decreases expression EXP 6480464 Arsenic Trioxide results in decreased expression of BCL2L2 mRNA CTD PMID:19730151 diarsenic trioxide multiple interactions ISO BCL2L2 (Homo sapiens) 6480464 [Arsenic Trioxide co-treated with Curcumin] affects the expression of BCL2L2 protein CTD PMID:27430728 diarsenic trioxide increases expression ISO BCL2L2 (Homo sapiens) 6480464 Arsenic Trioxide results in increased expression of BCL2L2 protein CTD PMID:27430728 dibutyl phthalate increases expression ISO Bcl2l2 (Mus musculus) 6480464 Dibutyl Phthalate results in increased expression of BCL2L2 mRNA CTD PMID:21266533 dibutyl phthalate increases expression EXP 6480464 Dibutyl Phthalate results in increased expression of BCL2L2 mRNA CTD PMID:21266533 dioxygen multiple interactions ISO BCL2L2 (Homo sapiens) 6480464 [Oxygen deficiency co-treated with Oxygen] results in decreased expression of BCL2L2 protein more ... CTD PMID:24557422 erlotinib hydrochloride multiple interactions ISO BCL2L2 (Homo sapiens) 6480464 [Niclosamide inhibits the reaction [Erlotinib Hydrochloride results in increased expression of BCL2L2 protein]] which results in increased susceptibility to Erlotinib Hydrochloride and Niclosamide inhibits the reaction [Erlotinib Hydrochloride results in increased expression of BCL2L2 protein] CTD PMID:23894143 erlotinib hydrochloride increases expression ISO BCL2L2 (Homo sapiens) 6480464 Erlotinib Hydrochloride results in increased expression of BCL2L2 mRNA and Erlotinib Hydrochloride results in increased expression of BCL2L2 protein CTD PMID:23894143 etoposide decreases response to substance ISO BCL2L2 (Homo sapiens) 6480464 BCL2L2 results in decreased susceptibility to Etoposide CTD PMID:14973057 folic acid multiple interactions ISO Bcl2l2 (Mus musculus) 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of BCL2L2 mRNA CTD PMID:20938992 folic acid decreases expression ISO Bcl2l2 (Mus musculus) 6480464 Folic Acid results in decreased expression of BCL2L2 mRNA CTD PMID:25629700 fulvestrant multiple interactions ISO BCL2L2 (Homo sapiens) 6480464 arsenite inhibits the reaction [Fulvestrant results in increased expression of BCL2L2 mRNA] more ... CTD PMID:31646340 fulvestrant increases expression ISO BCL2L2 (Homo sapiens) 6480464 Fulvestrant results in increased expression of BCL2L2 mRNA CTD PMID:31646340 furosemide affects expression EXP 6480464 Furosemide affects the expression of BCL2L2 mRNA CTD PMID:17497460 Fusarenone X increases expression ISO Bcl2l2 (Mus musculus) 6480464 fusarenon-X results in increased expression of BCL2L2 mRNA CTD PMID:24983900 gentamycin increases expression EXP 6480464 Gentamicins results in increased expression of BCL2L2 mRNA CTD PMID:18172885 geraniol decreases expression ISO BCL2L2 (Homo sapiens) 6480464 geraniol results in decreased expression of BCL2L2 protein CTD PMID:21371438 indometacin multiple interactions ISO BCL2L2 (Homo sapiens) 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of BCL2L2 mRNA CTD PMID:28628672 isoflurane decreases expression EXP 6480464 Isoflurane results in decreased expression of BCL2L2 mRNA CTD PMID:16978161 kojic acid multiple interactions ISO Bcl2l2 (Mus musculus) 6480464 [Diethylnitrosamine co-treated with kojic acid co-treated with Ascorbic Acid] results in increased expression of BCL2L2 mRNA CTD PMID:17917374 L-ascorbic acid multiple interactions ISO Bcl2l2 (Mus musculus) 6480464 [Diethylnitrosamine co-treated with kojic acid co-treated with Ascorbic Acid] results in increased expression of BCL2L2 mRNA CTD PMID:17917374 L-methionine multiple interactions ISO Bcl2l2 (Mus musculus) 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of BCL2L2 mRNA CTD PMID:20938992 lidocaine decreases expression EXP 6480464 Lidocaine results in decreased expression of BCL2L2 mRNA CTD PMID:35283115 methamphetamine increases expression ISO Bcl2l2 (Mus musculus) 6480464 Methamphetamine results in increased expression of BCL2L2 mRNA CTD PMID:26307267 methapyrilene decreases expression EXP 6480464 Methapyrilene results in decreased expression of BCL2L2 mRNA CTD PMID:30467583 methoxyacetic acid affects expression EXP 6480464 methoxyacetic acid affects the expression of BCL2L2 protein CTD PMID:10809232 methylparaben increases expression ISO BCL2L2 (Homo sapiens) 6480464 methylparaben results in increased expression of BCL2L2 mRNA CTD PMID:24481588 Mitotane increases expression EXP 6480464 Mitotane results in increased expression of BCL2L2 mRNA CTD PMID:23485034 monocrotophos decreases expression EXP 6480464 Monocrotophos results in decreased expression of BCL2L2 mRNA and Monocrotophos results in decreased expression of BCL2L2 protein CTD PMID:20957986 and PMID:21445290 N-methyl-4-phenylpyridinium increases expression ISO BCL2L2 (Homo sapiens) 6480464 1-Methyl-4-phenylpyridinium results in increased expression of BCL2L2 mRNA CTD PMID:26364587 N-methyl-4-phenylpyridinium multiple interactions ISO BCL2L2 (Homo sapiens) 6480464 INS protein promotes the reaction [1-Methyl-4-phenylpyridinium results in increased expression of BCL2L2 mRNA] CTD PMID:26364587 N-nitrosodiethylamine multiple interactions ISO Bcl2l2 (Mus musculus) 6480464 [Diethylnitrosamine co-treated with kojic acid co-treated with Ascorbic Acid] results in increased expression of BCL2L2 mRNA CTD PMID:17917374 nickel dichloride affects expression EXP 6480464 nickel chloride affects the expression of BCL2L2 mRNA CTD PMID:22546817 niclosamide decreases expression ISO BCL2L2 (Homo sapiens) 6480464 Niclosamide results in decreased expression of BCL2L2 protein CTD PMID:23894143 niclosamide multiple interactions ISO BCL2L2 (Homo sapiens) 6480464 [Niclosamide inhibits the reaction [Erlotinib Hydrochloride results in increased expression of BCL2L2 protein]] which results in increased susceptibility to Erlotinib Hydrochloride and Niclosamide inhibits the reaction [Erlotinib Hydrochloride results in increased expression of BCL2L2 protein] CTD PMID:23894143 p-menthan-3-ol increases expression ISO BCL2L2 (Homo sapiens) 6480464 Menthol results in increased expression of BCL2L2 mRNA CTD PMID:26760959 paracetamol affects expression ISO BCL2L2 (Homo sapiens) 6480464 Acetaminophen affects the expression of BCL2L2 mRNA CTD PMID:25704631 paracetamol multiple interactions ISO Bcl2l2 (Mus musculus) 6480464 [saikosaponin D co-treated with Acetaminophen] results in decreased expression of BCL2L2 mRNA CTD PMID:25265579 paraquat multiple interactions ISO Bcl2l2 (Mus musculus) 6480464 GPX1 protein affects the reaction [Paraquat affects the expression of BCL2L2 mRNA] CTD PMID:12654481 perfluorooctane-1-sulfonic acid multiple interactions ISO Bcl2l2 (Mus musculus) 6480464 [perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of BCL2L2 mRNA CTD PMID:36331819 picoxystrobin decreases expression ISO BCL2L2 (Homo sapiens) 6480464 picoxystrobin results in decreased expression of BCL2L2 mRNA CTD PMID:33512557 pinostrobin decreases expression ISO BCL2L2 (Homo sapiens) 6480464 pinostrobin results in decreased expression of BCL2L2 mRNA CTD PMID:37164308 propylparaben increases expression ISO BCL2L2 (Homo sapiens) 6480464 propylparaben results in increased expression of BCL2L2 mRNA CTD PMID:24481588 pyrazinecarboxamide decreases expression EXP 6480464 Pyrazinamide results in decreased expression of BCL2L2 mRNA CTD PMID:22431067 quercetin increases expression ISO BCL2L2 (Homo sapiens) 6480464 Quercetin results in increased expression of BCL2L2 mRNA CTD PMID:21632981 resveratrol increases expression ISO BCL2L2 (Homo sapiens) 6480464 resveratrol results in increased expression of BCL2L2 mRNA CTD PMID:22748497 and PMID:22971900 resveratrol multiple interactions ISO BCL2L2 (Homo sapiens) 6480464 resveratrol inhibits the reaction [[Oxygen deficiency co-treated with Oxygen] results in decreased expression of BCL2L2 protein] CTD PMID:24557422 rotenone decreases expression ISO Bcl2l2 (Mus musculus) 6480464 Rotenone results in decreased expression of BCL2L2 mRNA CTD PMID:23186747 rotenone decreases expression ISO BCL2L2 (Homo sapiens) 6480464 Rotenone results in decreased expression of BCL2L2 mRNA CTD PMID:33512557 silver atom decreases expression ISO BCL2L2 (Homo sapiens) 6480464 Silver results in decreased expression of BCL2L2 mRNA CTD PMID:21611810 silver(0) decreases expression ISO BCL2L2 (Homo sapiens) 6480464 Silver results in decreased expression of BCL2L2 mRNA CTD PMID:21611810 simazine decreases expression ISO Bcl2l2 (Mus musculus) 6480464 Simazine results in decreased expression of BCL2L2 mRNA CTD PMID:25461544 sodium chromate decreases expression ISO BCL2L2 (Homo sapiens) 6480464 sodium chromate(VI) results in decreased expression of BCL2L2 mRNA CTD PMID:14971655 sunitinib decreases expression ISO BCL2L2 (Homo sapiens) 6480464 Sunitinib results in decreased expression of BCL2L2 mRNA CTD PMID:31533062 testosterone decreases expression ISO Bcl2l2 (Mus musculus) 6480464 Testosterone deficiency results in decreased expression of BCL2L2 mRNA CTD PMID:33848595 tetrathiomolybdate(2-) increases expression ISO BCL2L2 (Homo sapiens) 6480464 tetrathiomolybdate analog results in increased expression of BCL2L2 mRNA and tetrathiomolybdate analog results in increased expression of BCL2L2 protein CTD PMID:19323979 trichloroethene decreases methylation EXP 6480464 Trichloroethylene results in decreased methylation of BCL2L2 gene CTD PMID:27618143 triptonide affects expression ISO Bcl2l2 (Mus musculus) 6480464 triptonide affects the expression of BCL2L2 mRNA CTD PMID:33045310 troglitazone decreases expression ISO BCL2L2 (Homo sapiens) 6480464 troglitazone results in decreased expression of BCL2L2 mRNA and troglitazone results in decreased expression of BCL2L2 protein CTD PMID:16149072 tunicamycin increases expression ISO BCL2L2 (Homo sapiens) 6480464 Tunicamycin results in increased expression of BCL2L2 mRNA CTD PMID:22378314 valproic acid affects expression ISO Bcl2l2 (Mus musculus) 6480464 Valproic Acid affects the expression of BCL2L2 mRNA CTD PMID:17963808 valproic acid decreases response to substance ISO Bcl2l2 (Mus musculus) 6480464 BCL2L2 protein results in decreased susceptibility to Valproic Acid CTD PMID:19060243 valproic acid increases methylation ISO BCL2L2 (Homo sapiens) 6480464 Valproic Acid results in increased methylation of BCL2L2 gene CTD PMID:29154799 valproic acid affects expression ISO BCL2L2 (Homo sapiens) 6480464 Valproic Acid affects the expression of BCL2L2 mRNA CTD PMID:25979313 vorinostat decreases response to substance ISO Bcl2l2 (Mus musculus) 6480464 BCL2L2 protein results in decreased susceptibility to vorinostat CTD PMID:19060243 zoledronic acid increases expression ISO BCL2L2 (Homo sapiens) 6480464 zoledronic acid results in increased expression of BCL2L2 mRNA CTD PMID:19036117